单细胞DNA测序揭示了CHIP在移植符合条件的多发性髓瘤患者中的进化模式
Enrica Borsi1, Ilaria Vigliotta1, Andrea Poletti2
1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", 40138 Bologna, Italy.
Cells
|April 26, 2024
概括
在50%的多发性骨髓瘤患者中发现了不确定潜力 (CHIP) 突变的克隆造血,这表明治疗结果可能会更差,并且随着时间的推移,克隆扩张.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 不确定的潜力 (CHIP) 的克隆性血液形成包括导致克隆扩张的干细胞突变.
- CHIP在多发性骨髓瘤 (MM) 中普遍存在,并且与预后较差有关.
研究的目的:
- 研究在接受自身干细胞移植 (ASCT) 的MM患者中CHIP的存在和动态.
- 评估CHIP对治疗反应和克隆进化的影响.
主要方法:
- 来自12名MM患者的CD34+细胞的基于amplicon的高通量单细胞DNA测序.
- 使用MissionBio Tapestri平台对20个白血病相关基因进行有针对性的测序.
- 在ASCT之前和之后的4名患者的纵向样本分析.
主要成果:
- 在移植时,在50%的MM患者中检测到CHIP突变.
- 最常见的突变是在TET2,EZH2,KIT,DNMT3A和ASXL1.1中.
- 纵向数据显示,随着时间的推移,高适应性突变克隆的积极选择,无论子克隆的大小如何.
- 在CHIP阳性患者中,治疗反应往往低于最佳水平.
结论:
- 在MM患者中,CHIP是一个重要的发现,与克隆进化和潜在的较差治疗结果有关.
- 这项研究强调了CHIP克隆在移植后MM患者中的动态性质.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...